Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028
Triton’s report estimated that the nasal spray market in North America
is expected to propel at a CAGR of 8.31% during the evaluated years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market are:
• United States
• Canada
As per the National Center for Chronic Disease Prevention and Health
Promotion, a significant population suffers from obstructive pulmonary disease
in the region. This has led to severe breathing problems. Here, breathing
problems can also arise from lung cancer, tuberculosis, pneumonia, and other
chronic conditions. Additionally, in the US, several people are diagnosed with
hay fever or other allergies. This rise in conditions can be attributed to the
surge in air pollution levels across the region. Hence, the growth in
respiratory diseases supplements the development of the nasal spray market
within North America.
In the United States, as per the Department of Health and Human
Services, more than 25 million people have asthma, leading to high healthcare
expenditure. Moreover, many people suffer from chronic obstructive pulmonary
diseases, which cause breathing problems and other issues to arise. Further,
lung disease has emerged as the third leading cause of death in the country.
Other than this, allergic rhinitis and rhinosinusitis affect a significant
amount of the population, resulting in nasal congestion. This further increases
the need for nasal sprays.
Furthermore, there is a high prevalence of various conditions, including
idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and
others, among the growing elderly population in the country. Hence, these
factors are stimulating the adoption of nasal spray for various treatment
applications, simultaneously boosting the nasal spray market on a growth path
in the US.
Apotex Inc is a pharmaceutical company and is the largest producer of
generic medicines. Its product line includes fluticasone propionate nasal spray
that helps manage nasal systems of non-allergic rhinitis in adults and
pediatric patients above the age of four. The company exports its products to
over 100 countries. Besides, its divisions are focused on biosimilar development,
generics, and the manufacturing of transdermal solutions. Apotex is
headquartered in Toronto, Canada.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA NASAL SPRAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON NASAL SPRAY MARKET
2.2. KEY
INSIGHTS
2.2.1. ALLERGY
TREATMENTS WITH NASAL SPRAYS
2.2.2. UTILIZING
NASAL SPRAY FOR DIABETES
2.2.3. ENDOMETRIOSIS
TREATMENT WITH NASAL SPRAYS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. EMERGING
INTRANASAL VACCINES FOR COVID-19
2.7.2. INCREASING
ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION
2.7.3. GROWING
USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES
2.8. MARKET
CHALLENGES
2.8.1. COMPLICATIONS
DUE TO EXCESS USE OF NASAL SPRAYS
2.9. MARKET
OPPORTUNITIES
2.9.1. APPLICATION
OF NASAL SPRAYS IN TREATING DEPRESSION
2.9.2. USING
INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
2.9.3. EMPLOYING
NASAL SPRAY AS A VACCINE
3. NORTH
AMERICA NASAL SPRAY MARKET OUTLOOK - BY TYPE
3.1. DECONGESTION
NASAL SPRAY
3.2. STEROID
NASAL SPRAY
3.3. SALTWATER
SOLUTION/SALINE NASAL SPRAY
4. NORTH
AMERICA NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION
4.1. OVER-THE-COUNTER
4.2. PRESCRIBED
5. NORTH
AMERICA NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC
5.1. ANTIHISTAMINE
5.2. NASAL
STEROIDS
5.3. ANTICHOLINERGIC
5.4. MAST
CELL INHIBITOR
6. NORTH
AMERICA NASAL SPRAY MARKET OUTLOOK - BY APPLICATION
6.1. NASAL
CONGESTION
6.2. ALLERGIC
AND NON-ALLERGIC RHINITIS
6.3. VACCINATION
6.4. CNS
DISORDERS
6.5. OTHER
APPLICATIONS
7. NORTH
AMERICA NASAL SPRAY MARKET OUTLOOK - BY END-USER
7.1. HOME
CARE SETTING
7.2. ASC/CLINICS
7.3. PHARMACY
7.4. HOSPITAL
7.5. OTHER END-USERS
8. NORTH
AMERICA NASAL SPRAY MARKET – REGIONAL OUTLOOK
8.1. UNITED
STATES
8.2. CANADA
9. COMPETITIVE
LANDSCAPE
9.1. AKORN
9.2. ALLERGAN
9.3. APOTEX
INC
9.4. BHARAT
BIOTECH
9.5. CATALENT
INC
9.6. CIPLA
LIMITED
9.7. GLAXOSMITHKLINE
9.8. JOHNSON
AND JOHNSON
9.9. NOVARTIS
INTERNATIONAL AG
9.10. PFIZER
INC
9.11. PROCTOR
AND GAMBLE CO
9.12. SANOTIZE
RESEARCH AND DEVELOPMENT
9.13. SUN
PHARMACEUTICALS INDUSTRIES LTD
9.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
9.15. VIATRIS
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: NORTH AMERICA NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: NORTH AMERICA NASAL
SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA NASAL
SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA NASAL
SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA NASAL
SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA NASAL
SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: NORTH AMERICA NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE
3: NORTH AMERICA NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN
$ MILLION)
FIGURE
4: NORTH AMERICA NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $
MILLION)
FIGURE
5: NORTH AMERICA NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY,
2021-2028 (IN $ MILLION)
FIGURE
6: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)
FIGURE
7: NORTH AMERICA NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $
MILLION)
FIGURE
8: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE
9: NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)
FIGURE
10: NORTH AMERICA NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $
MILLION)
FIGURE
11: NORTH AMERICA NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $
MILLION)
FIGURE
12: NORTH AMERICA NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $
MILLION)
FIGURE
13: NORTH AMERICA NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $
MILLION)
FIGURE
14: NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
15: NORTH AMERICA NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $
MILLION)
FIGURE
16: NORTH AMERICA NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS,
2021-2028 (IN $ MILLION)
FIGURE
17: NORTH AMERICA NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE
18: NORTH AMERICA NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $
MILLION)
FIGURE
19: NORTH AMERICA NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE
20: NORTH AMERICA NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE
21: NORTH AMERICA NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $
MILLION)
FIGURE
22: NORTH AMERICA NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
23: NORTH AMERICA NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE
24: NORTH AMERICA NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE
25: NORTH AMERICA NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $
MILLION)
FIGURE
26: NORTH AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE
27: UNITED STATES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: CANADA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)